These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39204216)

  • 21. Altered gut microbiota composition in children and their caregivers infected with the SARS-CoV-2 Omicron variant.
    Wang YZ; Zhou JG; Lu YM; Hu H; Xiao FF; Ge T; Wang X; Zheng L; Yu LH; Le J; Yu H; Yu GJ; Xia Q; Zhang T; Zhou WH
    World J Pediatr; 2023 May; 19(5):478-488. PubMed ID: 36627507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naso-oropharyngeal microbiome from breast cancer patients diagnosed with COVID-19.
    Viana MC; Curty G; Furtado C; Singh B; Bendall ML; Viola JPB; de Melo AC; Soares MA; Moreira MAM
    Front Microbiol; 2022; 13():1074382. PubMed ID: 36713167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19.
    Ventero MP; Cuadrat RRC; Vidal I; Andrade BGN; Molina-Pardines C; Haro-Moreno JM; Coutinho FH; Merino E; Regitano LCA; Silveira CB; Afli H; López-Pérez M; Rodríguez JC
    Front Microbiol; 2021; 12():637430. PubMed ID: 33815323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of coronavirus-2 by real-time reverse transcription polymerase chain reaction in conjunctival swabs from patients with severe form of Coronavirus disease 2019 in São Paulo, Brazil.
    Misawa MAM; Tanaka T; Minelli T; Braga PGO; Kato JM; Gouvêa MSG; Pinho JRR; Yamamoto JH
    Clinics (Sao Paulo); 2021; 76():e2913. PubMed ID: 34287482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
    Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of respiratory microbiota in the protection against viral diseases: respiratory commensal bacteria as next-generation probiotics for COVID-19.
    Andrade BGN; Cuadrat RRC; Tonetti FR; Kitazawa H; Villena J
    Biosci Microbiota Food Health; 2022; 41(3):94-102. PubMed ID: 35846832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of oropharyngeal microbiota in healthcare workers post-COVID-19.
    Wei Y; Yu W; Zhang Z; Liu S; Xue J; Wu C; Gao Z; Guo S
    Front Cell Infect Microbiol; 2024; 14():1347345. PubMed ID: 38828262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oropharyngeal Microbiome Profiled at Admission is Predictive of the Need for Respiratory Support Among COVID-19 Patients.
    Bradley ES; Zeamer AL; Bucci V; Cincotta L; Salive MC; Dutta P; Mutaawe S; Anya O; Tocci C; Moormann A; Ward DV; McCormick BA; Haran JP
    medRxiv; 2022 Feb; ():. PubMed ID: 35262096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome.
    Shilts MH; Rosas-Salazar C; Strickland BA; Kimura KS; Asad M; Sehanobish E; Freeman MH; Wessinger BC; Gupta V; Brown HM; Boone HH; Patel V; Barbi M; Bottalico D; O'Neill M; Akbar N; Rajagopala SV; Mallal S; Phillips E; Turner JH; Jerschow E; Das SR
    Front Cell Infect Microbiol; 2021; 11():781968. PubMed ID: 35141167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oropharyngeal microbiome profiled at admission is predictive of the need for respiratory support among COVID-19 patients.
    Bradley ES; Zeamer AL; Bucci V; Cincotta L; Salive MC; Dutta P; Mutaawe S; Anya O; Tocci C; Moormann A; Ward DV; McCormick BA; Haran JP
    Front Microbiol; 2022; 13():1009440. PubMed ID: 36246273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial Biomarkers of the Oropharyngeal and Oral Cavity during SARS-CoV-2 Infection.
    Bourumeau W; Tremblay K; Jourdan G; Girard C; Laprise C
    Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of circulating bacterial profiles between mild and severe COVID-19 patients.
    Sivapornnukul P; Chitcharoen S; Sawaswong V; Tachaboon S; Dinhuzen J; Srisawat N; Payungporn S
    Exp Biol Med (Maywood); 2023 May; 248(10):866-873. PubMed ID: 36946423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma.
    Lopes Dos Santos Santiago G; Brusselle G; Dauwe K; Deschaght P; Verhofstede C; Vaneechoutte D; Deschepper E; Jordens P; Joos G; Vaneechoutte M
    BMC Microbiol; 2017 May; 17(1):109. PubMed ID: 28486933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia.
    Marimón JM; Sorarrain A; Ercibengoa M; Azcue N; Alonso M; Vidaur L
    Sci Rep; 2023 Oct; 13(1):17724. PubMed ID: 37853062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
    Sokol H; Contreras V; Maisonnasse P; Desmons A; Delache B; Sencio V; Machelart A; Brisebarre A; Humbert L; Deryuter L; Gauliard E; Heumel S; Rainteau D; Dereuddre-Bosquet N; Menu E; Ho Tsong Fang R; Lamaziere A; Brot L; Wahl C; Oeuvray C; Rolhion N; Van Der Werf S; Ferreira S; Le Grand R; Trottein F
    Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33685349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of COVID-19 Lockdown on the Nasopharyngeal Microbiota of Children and Adults Self-Confined at Home.
    Rocafort M; Henares D; Brotons P; Launes C; Fernandez de Sevilla M; Fumado V; Barrabeig I; Arias S; Redin A; Ponomarenko J; Mele M; Millat-Martinez P; Claverol J; Balanza N; Mira A; Garcia-Garcia JJ; Bassat Q; Jordan I; Muñoz-Almagro C
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
    Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
    Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing.
    Rueca M; Fontana A; Bartolini B; Piselli P; Mazzarelli A; Copetti M; Binda E; Perri F; Gruber CEM; Nicastri E; Marchioni L; Ippolito G; Capobianchi MR; Di Caro A; Pazienza V
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.